Shares of Arm Holdings surged as CEO Rene Haas delivered his most bullish comments yet on the company's data-center ambitions, telling CNBC's Jim Cramer that his confidence in converting $2 billion of demand for Arm's new AI-focused processor into actual revenue has grown steadily — from May to July, and again from July to September. The stock is now up roughly 15% in four trading sessions, but the gap between booked demand and shipped product remains the central question for investors.
Demand Doubled in Eight Weeks, but Arm Still Won't Raise Its Official Target
Demand for Arm's data-center processor surged from $1 billion in March 2026 to over $2 billion by May 2026 — a doubling in roughly eight weeks. Yet Arm has kept its official revenue target at a conservative $1 billion, and that gap between visible demand and stated goals tells you something about how seriously the company takes the supply constraints. Until management formally raises guidance, the extra $1 billion is a promise, not a plan.
The Real Bottleneck Isn't Customers — It's Chip Factories
Arm has secured manufacturing capacity to support the $1 billion opportunity but is still working with partners to expand further; Haas said the market is "very, very tight" across memory, test equipment, substrates, and wafers.
If Arm can't lock down enough factory time, $2 billion in demand simply won't convert into revenue, and the stock gives back its recent gains.
Selling Whole Chips Changes Arm's Business — and Its Margins
For decades, Arm's model was to design processor blueprints, license them to other companies, and collect royalties while someone else handled manufacturing. Now it's selling complete chips directly. Initial profit margins on those chips are expected in the low 40% range, which will dilute profitability compared to Arm's core licensing business.
Haas claims "data center is going to be our largest business" — a pivot that changes customer concentration, deal size, and profit trajectory for a company built on smartphone royalties.
The Stock Is Cheaper Than It Looks — Relative to Its Peak
At $275.53, Arm is still trading about 45% below the $452 peak it hit in June.
The average analyst 12-month price target from 39 analysts sits at roughly $286 , suggesting modest near-term upside. But with a trailing price-to-earnings ratio around 247 times , investors are paying a steep premium for a future that hinges entirely on whether factory floors can match the CEO's growing optimism.